Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 01:59 pm IST
Share
Ahn-Gook Pharmaceutical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 0.00013 million compared to negative sales of KRW 0.0003 million a year ago. Net income was KRW 695.62 million compared to KRW 1,193.37 million a year ago. Basic earnings per share from continuing operations was KRW 61 compared to KRW 105 a year ago. Diluted earnings per share from continuing operations was KRW 61 compared to KRW 105 a year ago. Basic earnings per share was KRW 61 compared to KRW 105 a year ago.
For the six months, negative sales was KRW 0.00008 million compared to KRW 0.0001 million a year ago. Net income was KRW 3,378.74 million compared to KRW 2,453.47 million a year ago. Basic earnings per share from continuing operations was KRW 297 compared to KRW 215 a year ago. Diluted earnings per share from continuing operations was KRW 297 compared to KRW 215 a year ago. Basic earnings per share was KRW 297 compared to KRW 215 a year ago.
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.